William Blair Starts Inovalon Holdings (INOV) at Outperform

Citi Starts Inovalon Holdings (INOV) at Neutral

Citi initiated coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $31.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

Goldman Sachs Starts Inovalon Holdings (INOV) at Neutral

Goldman Sachs initiated coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $30.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

UBS Starts Inovalon Holdings (INOV) at Buy

UBS initiated coverage on Inovalon Holdings (NASDAQ: INOV) with a Buy rating and a price target of $35.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

Baird Starts Inovalon Holdings (INOV) at Outperform

Baird initiated coverage on Inovalon Holdings (NASDAQ: INOV) with an Outperform rating and a price target of $36.00.

For an analyst ratings summary and ratings history on Inovalon Holdings click here. For more ratings news on Inovalon Holdings click here.

Shares of Inovalon Holdings closed at $30.53 yesterday.

Piper Jaffray Starts Inovalon Holdings (INOV) at Neutral

Piper Jaffray initiates coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $31.00.

Analyst Sean Wieland commented, "Inovalon is an integrated stack of health care data analytics and interventional processes that combined deliver risk adjustment and regulatory reporting... More

BofA/Merrill Lynch Starts Inovalon Holdings (INOV) at Neutral

BofA/Merrill Lynch initiates coverage on Inovalon Holdings (NASDAQ: INOV) with a Neutral rating and a price target of $33.00.

Analyst Robert Willoughby said while the company's analytics capabilities are unmatched in terms of insight and processing speed, with shares up 13.1% since its February 11... More